Michael E. Pape
Board of Directors @ Base4 Biotechnology
Orlando, United States
Michael E. Pape is a startup investor at Base4 Biotechnology in Orlando. Dr. Michael E. (Mike) Pape, Ph.D. serves as Partner of Orchard Venture Partners. Dr. Pape is Cofounder of Nymirum, Inc and serves as its Chief Scientific Officer and Chief Executive Officer. Dr. Pape served as the President at Nymirum, Inc. In 1998, he left Parke-Davis to co-found Esperion Therapeutics, where Dr. Pape led a variety of initiativesinvolving aspects of both science and business while holding several executive positions. He served as a Vice President of Cellular and Molecular Biology at Esperion Therapeutics, inc. Prior to Esperion, Dr. Pape held research positions in the Department of Metabolic Diseases at The Upjohn Company (now Pfizer) in Kalamazoo, Michigan and in the Departments of Atherosclerosis and Molecular Biology at Parke-Davis Pharmaceutical Research (now Pfizer) in Ann Arbor, Michigan. He and his research teams have published numerous articles detailing the biochemistry of atherosclerosis, diabetes, and obesity with an emphasis on the mechanism by which drugs can alter these diseases. Dr. Pape serves as Scientific Advisor at Apjohn Ventures Fund. He serves as Observer of Akebia Therapeutics, Inc. He served as Director of ProNAi Therapeutics, Inc. He serves on the Board of Directors of the Michigan Biosciences Industry Association.
Last updated:
For AI agents: llms.txt
About Base4 Biotechnology
Nymirum is a venture-backed, privately held company that has developed the RNArchitect suite to rapidly solve high-resolution RNA 3D structures and a proprietary drug discovery platform that targets RNA with small molecules.
Base4 Biotechnology Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Josh Fairbank
CEO, Chairman, Founder
|
|||
|
Michael E. Pape
Board of Directors
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
